Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/10760296221110568
Abstract: Purpose: To assess costs and healthcare resource utilization (HCRU) associated with the use of idarucizumab for the reversal of dabigatran and andexanet alfa for the reversal of direct oral Factor Xa inhibitors. Methods: This retrospective… read more here.
Keywords: costs healthcare; alfa; reversal; healthcare resource ... See more keywords
An Integrated Procedure for Ex-Ante Evaluations of Refurbishment Costs in Healthcare Facilities
Sign Up to like & getrecommendations! Published in 2020 at "Sustainability"
DOI: 10.3390/su12187387
Abstract: This paper focuses on the valuation of refurbishment costs for healthcare facilities. The determination of the more reliable approach for experimental verification is a research topic of great interest, especially because previous literature on the… read more here.
Keywords: integrated procedure; procedure ante; refurbishment; healthcare facilities ... See more keywords